Literature DB >> 8893793

Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells.

P Vanlandschoot1, E Beirnaert, S Neirynck, X Saelens, W M Jou, W Fiers.   

Abstract

A/Victoria/3/75 (H3N2)-derived cDNA coding for a secreted haemagglutinin (HA0s) was cloned into the polyhedrin promoter-based pVL1392 transfer vector, and a recombinant baculovirus was isolated. 5 to 10 micrograms/ml of secreted HA were obtained following infection of Spodoptera frugiperda-9 cells. Gel filtration revealed the presence in the cell supernatant of immunoreactive HA molecules with varying M(r). The high M(r) fraction (aHA0s) could be purified by Matrex Cellufine Sulphate and Lentil-lectin affinity chromatography, followed by Sephacryl S300 HR gel filtration. aHA0s consisted of aggregated, non-covalently linked subunits which were not cleaved into HA1 and HA2 polypeptides; aHA0s was highly susceptible to trypsin treatment and reacted with two low pH-specific monoclonal antibodies, suggesting that a HA0s consists of monomeric subunits. When the expression medium was adjusted to pH 8.5, no aHA0s was observed, suggesting that aggregation occurred in the cells due to a low intracellular pH. Balb/c mice immunized with purified aHA0s developed high, aHA0s-specific antibody titres. Despite these high titres, almost no binding to trimeric viral HA was observed, and immunized mice were not protected against a challenge with homologous mouse-adapted X47 virus. However, when virus was subjected to low pH, resulting in a profound conformational rearrangement, strong binding was observed. Moreover, binding to the low pH-treated HA of different drift variants, isolated between 1968 and 1989, occurred.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893793     DOI: 10.1007/bf01718294

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector.

Authors:  K Kuroda; H Geyer; R Geyer; W Doerfler; H D Klenk
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

3.  Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.

Authors:  M Ohuchi; A Cramer; M Vey; R Ohuchi; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Reduced extracellular pH reversibly inhibits oligomerization, intracellular transport, and processing of the influenza hemagglutinin in infected Madin-Darby canine kidney cells.

Authors:  K S Matlin; J Skibbens; P L McNeil
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

5.  Recombinant neuraminidase vaccine protects against lethal influenza.

Authors:  T Deroo; W M Jou; W Fiers
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

6.  Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein.

Authors:  M J Gething; J Sambrook
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

7.  Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector.

Authors:  K Kuroda; C Hauser; R Rott; H D Klenk; W Doerfler
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

8.  The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway.

Authors:  F Boulay; R W Doms; I Wilson; A Helenius
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

9.  Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP).

Authors:  S M Hurtley; D G Bole; H Hoover-Litty; A Helenius; C S Copeland
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation.

Authors:  S A Wharton; L J Calder; R W Ruigrok; J J Skehel; D A Steinhauer; D C Wiley
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  7 in total

1.  A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.

Authors:  Yoko Shoji; R Mark Jones; Vadim Mett; Jessica A Chichester; Konstantin Musiychuk; Xiangjie Sun; Terrence M Tumpey; Brian J Green; Moneim Shamloul; Joey Norikane; Hong Bi; Caitlin E Hartman; Cory Bottone; Michelle Stewart; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

2.  Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.

Authors:  Yoko Shoji; Alex Prokhnevsky; Brett Leffet; Nancy Vetter; Stephen Tottey; Shama Satinover; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; R Mark Jones; Jessica A Chichester; Brian J Green; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Authors:  William C Weldon; Bao-Zhong Wang; Maria P Martin; Dimitrios G Koutsonanos; Ioanna Skountzou; Richard W Compans
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

4.  Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.

Authors:  Jyothi K Mallajosyula; Ernie Hiatt; Steve Hume; Ashley Johnson; Trushar Jeevan; Rachel Chikwamba; Gregory P Pogue; Barry Bratcher; Hugh Haydon; Richard J Webby; Alison A McCormick
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

5.  Downstream Processing: From Egg to Cell Culture-Derived Influenza Virus Particles.

Authors:  M W Wolff; U Reichl
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

6.  Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried forms.

Authors:  Didier Clénet; Léna Clavier; Benoît Strobbe; Christel Le Bon; Manuela Zoonens; Aure Saulnier
Journal:  Biotechnol Bioeng       Date:  2021-08-05       Impact factor: 4.395

7.  Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections.

Authors:  Valentina Bernasconi; Beatrice Bernocchi; Liang Ye; Minh Quan Lê; Ajibola Omokanye; Rodolphe Carpentier; Karin Schön; Xavier Saelens; Peter Staeheli; Didier Betbeder; Nils Lycke
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.